Firm in its social commitment, Abyntek Biopharma collaborates with the Breast Cancer Research Group integrated in the Oncology Area of BioDonostia HRI allocating part of the turnover of its Abyntek Researh Reagents line to finance projects that contribute to the fight against cancer.
In this article, we go deeply into the research project on the role of chronic inflammation and pro-inflammatory cytokines in breast cancer metastasis: